<DOC>
	<DOCNO>NCT01545739</DOCNO>
	<brief_summary>The Evia HF-T Entovis HF-T triple-chamber pacemaker cardiac resynchronisation therapy ( CRT-P ) . The objective study prove safety efficacy pacemaker . In particular , leave ventricular ( LV ) capture control feature evaluate , automatically measure LV pace threshold subsequently adjust pace output .</brief_summary>
	<brief_title>Evia/Entovis HF-T Master Study</brief_title>
	<detailed_description />
	<criteria>Standard indication CRT therapy Legal capacity ability consent Signed patient inform consent Contraindication CRT therapy ICD indication Age &lt; 18 year Pregnant breastfeed woman Cardiac surgery plan within next 6 month Life expectancy le 6 month Participating another clinical study investigational cardiac drug device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Pacemaker therapy</keyword>
	<keyword>Cardiac resynchronisation therapy ( CRT )</keyword>
</DOC>